Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine

Surveillance of impact of PCV-10 vaccine on pneumococcal meningitis in Mozambique, 2013 – 2015

(2017) Aquino Albino Nhantumbo et al.   PLoS One

Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi

(2017) Chrispin Chaguza et al.   VACCINE

Meningitis Outbreak Caused by Vaccine-Preventable Bacterial Pathogens — Northern Ghana, 2016

(2017) Fortress Y. Aku et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana

(2016) Brenda Anna Kwambana-Adams et al.   BMC INFECTIOUS DISEASES

Long-term Impact of a “3 + 0” Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002–2014

(2016) Sanjay Jayasinghe et al.   CLINICAL INFECTIOUS DISEASES

Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA Extraction

(2016) Jeni Vuong et al.   PLoS One

Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine—Burkina Faso, 2011–2013

(2016) Dinanibè Kambiré et al.   PLoS One

Climate Change and Cerebrospinal Meningitis in the Ghanaian Meningitis Belt

(2014) Samuel Codjoe et al.   International Journal of Environmental Research and Public Health

Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine Administered According to 4 Different Primary Immunization Schedules in Infants

(2013) Judith Spijkerman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sequential Triplex Real-Time PCR Assay for Detecting 21 Pneumococcal Capsular Serotypes That Account for a High Global Disease Burden

(2012) F. C. Pimenta et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose

(2011) K.P. Klugman et al.   VACCINE

African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults

(2010) Bradford D Gessner et al.   BMC INFECTIOUS DISEASES

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine

(2009) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia

(2008) M. Saaka et al.   VACCINE